The association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder

Journal of Clinical Psychopharmacology

Volumn 33, Issue 4, 2013, Pages 556-560

  Van Voorhees, Elizabeth E ^a,b   Dennis, Michelle F ^b   McClernon, F Joseph ^a,b   Calhoun, Patrick S ^a,b   Buse, Natalie A ^b   Beckham, Jean C ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

DHEA; negative affect; posttraumatic stress disorder; smoking

Indexed keywords

ANTIDEPRESSANT AGENT; NICOTINE; PRASTERONE; PRASTERONE SULFATE;

ADULT; AFFECT; ANXIETY; ANXIETY SENSITIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEAR; FEMALE; HELPLESSNESS; HORMONE BLOOD LEVEL; HUMAN; MALE; MOOD; NEGATIVE AFFECT; PATIENT MONITORING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SELF REPORT; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE;

ADULT; AFFECT; ANXIETY; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SELF REPORT; SMOKING; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84879840753     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182968962     Document Type: Article

References (52)

1. Feldner MT, Babson KA, Zvolensky MJ. Smoking, traumatic event exposure, and post-traumatic stress: a critical review of the empirical literature. Clin Psychol Rev. 2007;27(1):14-45.
2. Fu SS, McFall M, Saxon AJ, et al. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res. 2007;9(11):1071-1084.
3. Beckham JC, Roodman AA, Shipley RH, et al. Smoking in Vietnam combat veterans with post-traumatic stress disorder. J Trauma Stress. 1995;8(3):461-472.
4. Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003;60(3):289-294.
5. Evatt DP, Kassel JD. Smoking, arousal, and affect: the role of anxiety sensitivity. J Anxiety Disord. 2010;24(1):114-123.
6. Marx CE, Trost WT, Shampine L, et al. Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology (Berl). 2006;186(3):462-472.
7. Mello NK. Hormones, nicotine, and cocaine: clinical studies. Horm Behav. 2010;58(1):57-71.
8. Mendelson JH, Sholar MB, Goletiani N, et al. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology. 2005;30(9):1751-1763.
9. Oncken C, Prestwood K, Cooney JL, et al. Effects of smoking cessation or reduction on hormone profiles and bone turnover in postmenopausal women. Nicotine Tob Res. 2002;4(4):451-458.
10. Rasmusson AM, Wu R, Paliwal P, et al. A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study. Psychopharmacology (Berl). 2006;186(3):473-480.
11. Rasmusson AM, Picciotto MR, Krishnan-Sarin S. Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. J Psychopharmacol. 2006;20(5):693-707.
12. Kroboth PD, Salek FS, Pittenger AL, et al. DHEA and DHEA-S: a review. J Clin Pharmacol. 1999;39(4):327-348.
13. Maninger N, Wolkowitz OM, Reus VI, et al. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009;30(1):65-91.
14. Olff M, de Vries GJ, Guzelcan Y, et al. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD. Psychoneuroendocrinology. 2007;32(6):619-626.
15. Rasmusson AM, Vasek J, Lipschitz DS, et al. An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology. 2004;29(8):1546-1557.
16. Yehuda R, Brand SR, Golier JA, et al. Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr Scand. 2006;114(3):187-193.
17. Wilkins JN, Majewska MD, Van Gorp W, et al. DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology. 2005;30(1):18-28.
18. Schmidt PJ, Daly RC, Bloch M, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005;62(2):154-162.
19. Wolkowitz OM, Reus VI, Keebler A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999;156(4):646-649.
20. Baron JA, Comi RJ, Cryns V, et al. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995;272(1):151-155.
21. Field C. Examining factors that influence the uptake of smoking in women. Br J Nurs. 2008;17(15):980-985.
22. Ceballos NA, al'Absi M. Dehydroepiandrosterone sulfate, cortisol, mood state and smoking cessation: relationship to relapse status at 4-week follow-up. Pharmacol Biochem Behav. 2006;85(1):23-28.
23. Cook JW, McFall MM, Calhoun PS, et al. Posttraumatic stress disorder and smoking relapse: a theoretical model. J Trauma Stress. 2007;20(6):989-998.
24. Perkins KA, Karelitz JL, Giedgowd GE, et al. Differences in negative mood-induced smoking reinforcement due to distress tolerance, anxiety sensitivity, and depression history. Psychopharmacology (Berl). 2010;210(1):25-34.
25. Shiffman S, Waters AJ. Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol. 2004;72(2):192-201.
26. Berenz EC, Vujanovic AA, Coffey SF, et al. Anxiety sensitivity and breath-holding duration in relation to PTSD symptom severity among trauma exposed adults. J Anxiety Disord. 2012;26(1):134-139.
27. Zvolensky MJ, Stewart SH, Vujanovic AA, et al. Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment. Nicotine Tob Res. 2009;11(3):323-331.
28. Calhoun PS, Levin HF, Dedert EA, et al. The relationship between posttraumatic stress disorder and smoking outcome expectancies among U.S. military veterans who served since September 11, 2001. J Trauma Stress. 2011;24(3):303-308.
29. Carmody TP, McFall M, Saxon AJ, et al. Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder. Nicotine Tob Res. 2012;14(8):919-926.
30. Morales AJ, Nolan JJ, Nelson JC, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78(6):1360-1367.
31. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90.
32. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001;13(3):132-156.
33. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV-TR (SCID-I)-Research Version. New York, NY: Biometrics Research; 2002.
34. Deacon BJ, Abramowitz JS, Woods CM, et al. The Anxiety Sensitivity IndexYRevised: psychometric properties and factor structure in two nonclinical samples. Behav Res Ther. 2003;41(12):1427-1449.
35. Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2008;33(2):312-319.
36. Maller RG, Reiss S. Anxiety sensitivity in 1984 and panic attacks in 1987. J Anxiety Disord. 1992;6(3):241-247.
37. Taylor S, Cox BJ. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord. 1998;12(5):463-483.
38. Telch MJ, Lucas JA, Nelson P. Nonclinical panic in college students: an investigation of prevalence and symptomatology. J Abnorm Psychol. 1989;98(3):300-306.
39. Peterson RA, Reiss S. Test Manual for the Anxiety Sensitivity Index. Orlando Park, IL: International Diagnostic Systems; 1992.
40. Watson D, Clark LA, Carey G. Positive and negative affectivity and their relation to anxiety and depressive disorders. J Abnorm Psychol. 1988;97(3):346-353.
41. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070.
42. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
43. Deuschle M, Luppa P, Gilles M, et al. Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine. Neuropsychobiology. 2004;50(3):252-256.
44. Van den Berghe G, de Zegher F, Wouters P, et al. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf ). 1995;43(4):457-463.
45. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
46. Beckham JC, Feldman ME, Vrana SR, et al. Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder: a preliminary study. Exp Clin Psychopharmacol. 2005;13(3):219-228.
47. Beckham JC, Wiley MT, Miller SC, et al. Ad lib smoking in post-traumatic stress disorder: an electronic diary study. Nicotine Tob Res. 2008;10(7):1149-1157.
48. Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005;62(10):1142-1147.
49. Shoptaw S, Majewska MD, Wilkins J, et al. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp Clin Psychopharmacol. 2004;12(2):126-135.
50. Gatti R, De Palo EF. An update: salivary hormones and physical exercise. Scand J Med Sci Sports. 2011;21(2):157-169.
51. Perez-Neri I, Montes S, Ojeda-Lopez C, et al. Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1118-1130.
52. Dickstein BD, Suvak M, Litz BT, et al. Heterogeneity in the course of posttraumatic stress disorder: trajectories of symptomatology. J Trauma Stress. 2010;23(3):331-339.